Myles Wolf
Director/Board Member chez AKEBIA THERAPEUTICS, INC.
Fortune : 123 856 $ au 31/03/2024
Profil
Myles Wolf is currently the Chairman-North American Region at World Kidney Fund - International Society of Nephrology, an Independent Director at Akebia Therapeutics, Inc., and a Professor at Duke University School of Medicine.
He has an undergraduate degree from The Johns Hopkins University and New York University, a doctorate degree from Harvard Medical School, and a graduate degree from The State University of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/06/2023 | 67 681 ( 0,03% ) | 123 856 $ | 31/03/2024 |
Postes actifs de Myles Wolf
| Sociétés | Poste | Début |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Director/Board Member | 06/04/2020 |
| Duke University School of Medicine | Corporate Officer/Principal | 01/01/2002 |
| The International Society of Nephrology (Belgium) | Corporate Officer/Principal | - |
Formation de Myles Wolf
| The Johns Hopkins University | Undergraduate Degree |
| The State University of New York | Graduate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| The International Society of Nephrology (Belgium) |
